APA (7th ed.) Citation

K, O., M, W., Y, M., H, Y., K, K., K, I., . . . K, O. (2026). Cost-effectiveness of implantable cardioverter-defibrillators for primary prevention in heart failure with reduced ejection fraction: A Markov model using JROAD-DPC cost data in Japan. Frontiers in cardiovascular medicine, 13, 1744517. https://doi.org/10.3389/fcvm.2026.1744517

Chicago Style (17th ed.) Citation

K, Ohashi, et al. "Cost-effectiveness of Implantable Cardioverter-defibrillators for Primary Prevention in Heart Failure with Reduced Ejection Fraction: A Markov Model Using JROAD-DPC Cost Data in Japan." Frontiers in Cardiovascular Medicine 13 (2026): 1744517. https://doi.org/10.3389/fcvm.2026.1744517.

MLA (9th ed.) Citation

K, Ohashi, et al. "Cost-effectiveness of Implantable Cardioverter-defibrillators for Primary Prevention in Heart Failure with Reduced Ejection Fraction: A Markov Model Using JROAD-DPC Cost Data in Japan." Frontiers in Cardiovascular Medicine, vol. 13, 2026, p. 1744517, https://doi.org/10.3389/fcvm.2026.1744517.